Key facts
- IBEX Medical Systems’s last known valuation is $59.4M (May 2025).
- It has raised $17.5M; the latest was Later Stage VC ($10.0M) in May 2025.
- Notable investors include Tech Incubator Program for Startup, Smilegate Investment, Capstone Partners Korea, Roy Investment Partners, Bithumb — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for IBEX Medical Systems
- ·The full record, as it builds
Funding rounds
No funding rounds for IBEX Medical Systems are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About IBEX Medical Systems
Developer of an automatic control and mirroring system designed to offer quick and accurate operational service through simpler operation using an LCD touch screen. The company's system offers a hyperbaric oxygen chamber that is designed and manufactured to meet the stringent design standard of hyperbaric pressure vessel and international certification standards as required by hyperbaric device design and production dimension, enabling users to check the internal chamber situations and patient information on mobile devices including tablet and smartphone, medical staffs can check it in real-time.
- Sector
- Healthcare
- HQ
- Wonju, South Korea
- Founded
- 2011
- Employees
- 8
- Website
- ibex.co.kr/
- Ownership
- Privately Held (backing)
IBEX Medical Systems doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in IBEX Medical Systems shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on IBEX Medical Systems in its N-PORT filings yet. We sweep new filings monthly.